Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
January 29, 2019
Patent Application Number
15453823
Date Filed
March 8, 2017
Patent Citations Received
...
Patent Primary Examiner
Patent abstract
This invention relates to methods of treating and ameliorating congenital and neonatal hyperinsulinism and post-prandial hypoglycemia, comprising the step of administering an antagonist of the Glucagon-Like Peptide-1 (GLP-1) receptor, e.g. a GLP-1 fragment or analog thereof.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
